Tri­al soft­ware group rais­es $45M to push de­cen­tral­ized stud­ies; $120M SPAC makes its way to Nas­daq

Af­ter watch­ing the en­tire clin­i­cal tri­al process go through a ma­jor makeover dur­ing the pan­dem­ic, an­oth­er soft­ware out­fit is mak­ing a play to help de­vel­op­ers get on the cut­ting edge of tri­al de­sign and de­cen­tral­ized ex­e­cu­tion.

Hobo­ken, NJ-based Cas­tor has just raised $45 mil­lion to fund de­vel­op­ment of soft­ware in­tend­ed to scale up their “di­rect-to-pa­tients” ap­proach glob­al­ly. This new round brings their to­tal fund­ing to $65 mil­lion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER